Author:

Anaissie EJ

Date: 17 April 2007

Abstract:

No abstract. First paragraph: Invasive aspergillosis causes high morbidity and mortality; thus, there is a need for more effective therapies. However, regulatory approval of new agents is based on the results of randomized clinical trials (RCTs), which take years and huge amounts of money to complete. Novel strategies to evaluate effective therapies for aspergillosis, quickly and efficiently, are urgently needed.

Link to DOI

Download the full article (Disclaimer)

This manuscript library of ~16,000 articles (1729-2024) related to Aspergillus and aspergillosis is intended for individual study only, and is provided as contribution to global understanding of the topic. Please refer to the publisher’s guidance about any other usage.

I understand (click to accept and view download link)

---